4.0 Article

Living Alone and Cardiovascular Risk in Outpatients at Risk of or With Atherothrombosis

期刊

ARCHIVES OF INTERNAL MEDICINE
卷 172, 期 14, 页码 1086-1095

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/archinternmed.2012.2782

关键词

-

资金

  1. TIMI Study Group
  2. AstraZeneca Pharmaceuticals LP
  3. Daiichi-Sankyo Inc
  4. Merck Co Inc
  5. Johnson & Johnson Pharmaceutical Research and Development LLC
  6. Bayer HealthCare Pharmaceuticals
  7. Bristol-Myers-Squibb Co
  8. Gilead Science
  9. Daiichi-Sankyo
  10. Maquet
  11. sanofi-aventis
  12. Eisai
  13. Boehringer-Ingelheim
  14. Amarin
  15. AstraZeneca
  16. Bristol-Myers Squibb
  17. Ethicon
  18. Medtronic
  19. Medicines Company
  20. Waksman Foundation (Tokyo, Japan)
  21. Canadian Institutes for Health Research
  22. Canadian Foundation for Women's Health

向作者/读者索取更多资源

Background: Living alone, a proxy for social support, has been inconsistently linked with cardiovascular risk. Methods: We investigated whether living alone was associated with increased mortality and cardiovascular risk in the global REduction of Atherothrombosis for Continued Health (REACH) Registry. Stable outpatients at risk of or with atherothrombosis were recruited from December 1, 2003, through December 31, 2004, and followed up to 4 years for cardiovascular events. Events were examined by living arrangement with risk adjustment for age, sex, clinical risk factors, therapy, preexisting vascular disease, and sociodemographic factors. Effect modification was tested by age, sex, employment, ethnicity, education, and geography. Results: Among the 44 573 REACH participants, 8594 (19%) were living alone. Living alone was associated with higher 4-year mortality (14.1% vs 11.1%) and cardiovascular death (8.6% vs 6.8%; log-rank P<.01 for both comparisons); however, there was significant effect modification by age (P value for interaction =.03). Specifically, among younger participants, living alone compared with those living with others was associated with higher mortality (age 45-65 years: 7.7% vs 5.7%; adjusted hazard ratio [HR], 1.24 195% CI, 1.01-1.511; age 66-80 years: 13.2% vs 12.3%; adjusted HR, 1.12 [95% CI, 1.01-1.261), but this was not observed among older participants (age > 80 years: 24.6% vs 28.4%; adjusted HR, 0.92 [95% CI, 0.79-1.061). A similar trend was observed for the risk of cardiovascular death. Conclusions: In an international outpatient population with atherothrombosis aged 45 years or older, living alone was associated with increased mortality among all but the most elderly patients, although this observation warrants confirmation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据